{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:02:26Z","timestamp":1790398946755,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.cyto.2021.155437","type":"journal-article","created":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T11:53:18Z","timestamp":1611489198000},"page":"155437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Meta-analysis of \u2212308G\u00a0>\u00a0A polymorphism in TNF\u03b1 gene and susceptibility to leishmaniasis"],"prefix":"10.1016","volume":"140","author":[{"given":"Raja\u00e2","family":"Ejghal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Charoute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasnaa","family":"Talimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rhazlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Lemrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2021.155437_b0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","article-title":"The increase in risk factors for leishmaniasis worldwide","volume":"95","author":"Desjeux","year":"2001","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"10.1016\/j.cyto.2021.155437_b0010","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2021.155437_b0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-3024.2009.01102.x","article-title":"Genetics and visceral leishmaniasis: of mice and man","volume":"31","author":"Blackwell","year":"2009","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.cyto.2021.155437_b0020","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pt.2004.08.009","article-title":"Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis","volume":"20","author":"Engwerda","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.cyto.2021.155437_b0025","first-page":"93","article-title":"Tumor necrosis factors: developments during the last decade","volume":"7","author":"Aggarwal","year":"1996","journal-title":"Eur Cytokine Netw."},{"key":"10.1016\/j.cyto.2021.155437_b0030","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/infdis\/163.4.853","article-title":"Tumor necrosis factor (cachectin) in human visceral leishmaniasis","volume":"163","author":"Barral-Netto","year":"1991","journal-title":"J Infect Dis."},{"key":"10.1016\/j.cyto.2021.155437_b0035","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.leukres.2011.11.016","article-title":"Tumor necrosis factor alpha-308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt","volume":"36","author":"Ibrahim","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cyto.2021.155437_b0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/1.5.353","article-title":"Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product","volume":"1","author":"Wilson","year":"1992","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.cyto.2021.155437_b0045","unstructured":"PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses. (n.d.). http:\/\/www.prisma-statement.org\/ (accessed October 23, 2020)."},{"key":"10.1016\/j.cyto.2021.155437_b0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12881-020-01043-9","article-title":"TNF-\u03b1 \u2212 308 G\/A and IFN-\u03b3 + 874 A\/T gene polymorphisms in Saudi patients with cutaneous leishmaniasis","volume":"21","author":"Ahmed","year":"2020","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.cyto.2021.155437_b0055","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.182.5.1259","article-title":"Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis","volume":"182","author":"Cabrera","year":"1995","journal-title":"J Exp Med."},{"key":"10.1016\/j.cyto.2021.155437_b0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cyto.2012.09.012","article-title":"Candidate gene case-control and functional study shows macrophage inhibitory factor (MIF) polymorphism is associated with cutaneous leishmaniasis","volume":"61","author":"de Jesus Fernandes","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155437_b0065","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2222-1808(14)60801-X","article-title":"Polymorphisms in tumor necrosis factor genes and susceptibility to visceral leishmaniasis in Moroccan children","volume":"5","author":"Ejghal","year":"2015","journal-title":"Asian Pacific Journal of Tropical Disease."},{"key":"10.1016\/j.cyto.2021.155437_b0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cyto.2006.07.016","article-title":"Cytokine gene polymorphisms and susceptibility to cutaneous leishmaniasis in Iranian patients","volume":"35","author":"Kamali-Sarvestani","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155437_b0075","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0198-8859(01)00237-3","article-title":"Association analysis of HLA-class II and class III gene polymorphisms in the susceptibility to mediterranean visceral leishmaniasis","volume":"62","author":"Meddeb-Garnaoui","year":"2001","journal-title":"Hum Immunol."},{"key":"10.1016\/j.cyto.2021.155437_b0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12879-017-2281-4","article-title":"Screening of TNF\u03b1, IL-10 and TLR4 single nucleotide polymorphisms in individuals with asymptomatic and chronic cutaneous leishmaniasis in Colombia: a pilot study","volume":"17","author":"Mera-Ram\u00edrez","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cyto.2021.155437_b0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.micinf.2015.01.001","article-title":"Association of leishmaniasis with TNF alpha promoter and SLC11A1 gene polymorphisms in patients of two endemic areas in Mexico","volume":"17","author":"Ortiz-Flores","year":"2015","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cyto.2021.155437_b0090","first-page":"632","article-title":"Candidate gene study of susceptibility to cutaneous leishmaniasis in Sri Lanka","volume":"15","author":"Samaranayake","year":"2010","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.cyto.2021.155437_b0095","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0415-2017","article-title":"TGF-\u03b21 polymorphism in American tegumentary leishmaniasis in a Southern Brazilian population","volume":"52","author":"Shehadeh","year":"2019","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.cyto.2021.155437_b0100","first-page":"59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis","volume":"169","author":"Heinzel","year":"1989","journal-title":"Evidence for expansion of distinct helper T cell subsets, J Exp Med."},{"key":"10.1016\/j.cyto.2021.155437_b0105","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.168.5.1675","article-title":"Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens","volume":"168","author":"Scott","year":"1988","journal-title":"J Exp Med."},{"key":"10.1016\/j.cyto.2021.155437_b0110","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2217\/imt.13.104","article-title":"Translating immune cell cross-talk into a treatment opportunity for visceral leishmaniasis","volume":"5","author":"Ali","year":"2013","journal-title":"Immunotherapy."},{"key":"10.1016\/j.cyto.2021.155437_b0115","first-page":"223","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease","volume":"8","author":"Kidd","year":"2003","journal-title":"Altern Med Rev."},{"key":"10.1016\/j.cyto.2021.155437_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.01520","article-title":"Fatal Leishmaniasis in the Absence of TNF Despite a Strong Th1 Response","volume":"6","author":"Fromm","year":"2016","journal-title":"Front Microbiol."},{"key":"10.1016\/j.cyto.2021.155437_b0125","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/jac\/dkr575","article-title":"Asiaticoside induces tumour-necrosis-factor-\u03b1-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains","volume":"67","author":"Bhaumik","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.cyto.2021.155437_b0130","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/371508a0","article-title":"Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria","volume":"371","author":"McGuire","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2021.155437_b0135","first-page":"32","article-title":"Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation","volume":"46","author":"Brinkman","year":"1995","journal-title":"J Inflamm."},{"key":"10.1016\/j.cyto.2021.155437_b0140","unstructured":"S. F, U. Ia, B. M, D. Ln, K. Dv, T. Rl, S. Fu, N. Sa, -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter, J Inflamm. 46 (1995) 42\u201350. https:\/\/europepmc.org\/article\/med\/8832971 (accessed October 23, 2020)."},{"key":"10.1016\/j.cyto.2021.155437_b0145","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1182\/blood.V91.10.3574","article-title":"Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin\u2019s lymphoma outcome","volume":"91","author":"Warzocha","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2021.155437_b0150","first-page":"503","article-title":"Visceral leishmaniasis and anti-TNF-alpha therapy: case report and review of the literature","volume":"27","author":"De Leonardis","year":"2009","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.cyto.2021.155437_b0155","first-page":"192","article-title":"Anti-Tumor Necrosis Factor-alpha Therapy Provokes Latent Leishmaniasis in a Patient with Rheumatoid Arthritis","volume":"39","author":"Franklin","year":"2009","journal-title":"Ann Clin Lab Sci."},{"key":"10.1016\/j.cyto.2021.155437_b0160","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.semarthrit.2013.01.006","article-title":"Leishmaniasis during anti-tumor necrosis factor therapy: report of 4 cases and review of the literature (additional 28 cases)","volume":"43","author":"Guedes-Barbosa","year":"2013","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.cyto.2021.155437_b0165","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.153.2.768","article-title":"Role and effect of TNF-alpha in experimental visceral leishmaniasis","volume":"153","author":"Tumang","year":"1994","journal-title":"J Immunol."},{"key":"10.1016\/j.cyto.2021.155437_b0170","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4049\/jimmunol.157.2.827","article-title":"Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication","volume":"157","author":"Vieira","year":"1996","journal-title":"J Immunol."},{"key":"10.1016\/j.cyto.2021.155437_b0175","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1128\/iai.62.4.1414-1420.1994","article-title":"Tumor necrosis factor alpha (TNF-alpha) and TNF-beta and their receptors in experimental cutaneous leishmaniasis","volume":"62","author":"de Kossodo","year":"1994","journal-title":"Infect Immun."},{"key":"10.1016\/j.cyto.2021.155437_b0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.humimm.2009.01.007","article-title":"Th1\/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production","volume":"70","author":"Castellano","year":"2009","journal-title":"Hum Immunol."},{"key":"10.1016\/j.cyto.2021.155437_b0185","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/intimm\/dxh313","article-title":"Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice","volume":"17","author":"Rosas","year":"2005","journal-title":"Int Immunol."},{"key":"10.1016\/j.cyto.2021.155437_b0190","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/IAI.71.8.4804-4807.2003","article-title":"Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity","volume":"71","author":"St\u00e4ger","year":"2003","journal-title":"Infect Immun."},{"key":"10.1016\/j.cyto.2021.155437_b0195","first-page":"1","article-title":"Effect of NRAMP1 gene polymorphism on levels of (TNF-\u03b11 and IL-1\u03b2) cytokines in cutaneous Leishmaniasis patients in Iraq, Journal of Immunology and Clinical","author":"Raheem","year":"2018","journal-title":"Microbiology"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662100017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662100017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:58:21Z","timestamp":1760907501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662100017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":39,"alternative-id":["S104346662100017X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155437","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meta-analysis of \u2212308G\u00a0>\u00a0A polymorphism in TNF\u03b1 gene and susceptibility to leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155437"}}